tiprankstipranks
Trending News
More News >
Akebia Therapeutics (AKBA)
NASDAQ:AKBA
US Market

Akebia Therapeutics (AKBA) Income Statement

Compare
1,575 Followers

Akebia Therapeutics Income Statement

Last quarter (Q3 2025), Akebia Therapeutics's total revenue was $58.77M, an increase of 57.01% from the same quarter last year. In Q3, Akebia Therapeutics's net income was $540.00K. See Akebia Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 160.18M$ 194.62M$ 292.48M$ 211.65M$ 294.64M
Gross Profit
$ 97.00M$ 120.47M$ 269.99M$ 130.16M$ 230.68M
Operating Expenses
$ 147.47M$ 166.73M$ 350.77M$ 394.66M$ 608.51M
Depreciation and Amortization
$ 37.50M$ 37.63M$ 37.70M$ 37.97M$ 34.69M
EBITDA
$ -13.72M$ -8.27M$ 3.06M$ -189.91M$ -139.83M
Operating Income
$ -50.47M$ -46.26M$ -80.78M$ -264.50M$ -377.83M
Other Income/Expenses
$ -18.94M$ -5.67M$ -13.45M$ -17.52M$ -7.01M
Pretax Income
$ -69.41M$ -51.92M$ -94.23M$ -282.02M$ -384.84M
Net Income
$ -69.41M$ -51.92M$ -94.23M$ -282.02M$ -384.84M
Per Share Metrics
Basic EPS
$ -0.33$ -0.28$ -0.58$ -1.48$ -2.53
Diluted EPS
$ -0.33$ -0.28$ -0.58$ -1.48$ -2.53
Weighted Average Shares Outstanding
210.95M 187.47M 182.78M 165.95M 138.46M
Weighted Average Shares Outstanding (Diluted)
210.95M 187.47M 182.78M 165.95M 138.46M
Currency in USD

Akebia Therapeutics Earnings and Revenue History